These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 17973239)
1. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. Storci G; Sansone P; Trere D; Tavolari S; Taffurelli M; Ceccarelli C; Guarnieri T; Paterini P; Pariali M; Montanaro L; Santini D; Chieco P; Bonafé M J Pathol; 2008 Jan; 214(1):25-37. PubMed ID: 17973239 [TBL] [Abstract][Full Text] [Related]
2. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. Sansone P; Storci G; Tavolari S; Guarnieri T; Giovannini C; Taffurelli M; Ceccarelli C; Santini D; Paterini P; Marcu KB; Chieco P; Bonafè M J Clin Invest; 2007 Dec; 117(12):3988-4002. PubMed ID: 18060036 [TBL] [Abstract][Full Text] [Related]
3. Carbonic Anhydrase 9 mRNA/microRNA34a Interplay in Hypoxic Human Mammospheres. De Carolis S; Bertoni S; Nati M; D'Anello L; Papi A; Tesei A; Cricca M; Bonafé M J Cell Physiol; 2016 Jul; 231(7):1534-41. PubMed ID: 26553365 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX. Chen CL; Chu JS; Su WC; Huang SC; Lee WY Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721 [TBL] [Abstract][Full Text] [Related]
5. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203 [TBL] [Abstract][Full Text] [Related]
6. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. Storci G; Sansone P; Mari S; D'Uva G; Tavolari S; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Chieco P; Marcu KB; Bonafè M J Cell Physiol; 2010 Nov; 225(3):682-91. PubMed ID: 20509143 [TBL] [Abstract][Full Text] [Related]
7. Beta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxia. D'Uva G; Bertoni S; Lauriola M; De Carolis S; Pacilli A; D'Anello L; Santini D; Taffurelli M; Ceccarelli C; Yarden Y; Montanaro L; Bonafé M; Storci G PLoS One; 2013; 8(11):e80742. PubMed ID: 24260469 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment. Sanguinetti A; Santini D; Bonafè M; Taffurelli M; Avenia N World J Surg Oncol; 2015 Mar; 13():129. PubMed ID: 25881039 [TBL] [Abstract][Full Text] [Related]
10. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer. Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580 [TBL] [Abstract][Full Text] [Related]
11. Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers. Yan M; Jene N; Byrne D; Millar EK; O'Toole SA; McNeil CM; Bates GJ; Harris AL; Banham AH; Sutherland RL; Fox SB Breast Cancer Res; 2011 Apr; 13(2):R47. PubMed ID: 21521526 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition. Ledaki I; McIntyre A; Wigfield S; Buffa F; McGowan S; Baban D; Li JL; Harris AL Oncotarget; 2015 Aug; 6(23):19413-27. PubMed ID: 26305601 [TBL] [Abstract][Full Text] [Related]
13. [Significance of carbonic anhydrase IX protein expression in molecular subtyping of breast cancers]. Li MP; Ren LF; Cai HG; Yang HY; Lu B; Zhang P; Bao L Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):182-5. PubMed ID: 23769438 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826 [TBL] [Abstract][Full Text] [Related]
15. [Hypoxia induces down-regulation of estrogen receptor alpha in human breast cancer]. Liu GY; Shen KW; Shao ZM; Shen ZZ Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):664-8. PubMed ID: 15777504 [TBL] [Abstract][Full Text] [Related]
16. Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells. Storci G; Bertoni S; De Carolis S; Papi A; Nati M; Ceccarelli C; Pirazzini C; Garagnani P; Ferrarini A; Buson G; Delledonne M; Fiorentino M; Capizzi E; Gruppioni E; Taffurelli M; Santini D; Franceschi C; Bandini G; Bonifazi F; Bonafé M Am J Pathol; 2013 Nov; 183(5):1688-1697. PubMed ID: 24036252 [TBL] [Abstract][Full Text] [Related]
17. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia. Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155 [TBL] [Abstract][Full Text] [Related]
19. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Helczynska K; Kronblad A; Jögi A; Nilsson E; Beckman S; Landberg G; Påhlman S Cancer Res; 2003 Apr; 63(7):1441-4. PubMed ID: 12670886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]